Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression

Keyphrases

• Anxiety-depression 100%
• Palmitoylethanolamide 100%
• Luteolin 100%
• Animal Models of Anxiety 100%
• Antidepressants 60%
• Anti-apoptotic Proteins 40%
• Depressive-like Behavior 40%
• Forced Swim Test 40%
• Elevated Plus Maze 40%
• Novelty Suppressed Feeding 40%
• Mouse Model 20%
• Novel Therapeutics 20%
• Protein Expression 20%
• Neurogenesis 20%
• Western Blot Analysis 20%
• Immunostaining 20%
• Neuroplasticity 20%
• B-cell Lymphoma 2 (Bcl-2) 20%
• Brain-derived Neurotrophic Factor 20%
• Immunohistochemical Method 20%
• Neurotrophic 20%
• Corticosterone 20%
• Open Arm 20%
• 129Sv 20%
• Immobility Time 20%
• Adult Hippocampal Neurogenesis 20%
• Hippocampal Neuroplasticity 20%
• Ultramicronized Palmitoylethanolamide 20%
• Compound Treatment 20%

Neuroscience

• Luteolin 100%
• Behavior (Neuroscience) 60%
• Antidepressant 60%
• Neurogenesis 40%
• Neuroplasticity 40%
• Elevated Plus Maze 40%
• Immunohistochemistry 20%
• Brain-Derived Neurotrophic Factor 20%
• Protein Expression 20%
• Corticosterone 20%
• Bcl-2-Associated X Protein 20%
• Protein Bcl 2 20%
• Western Blotting 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Luteolin 100%
• Palmitoylethanolamide 100%
• Antidepressant 60%
• Mouse Model 20%
• Western Blot 20%
• Brain Derived Neurotrophic Factor 20%
• Protein Bax 20%
• Corticosterone 20%
• Protein Bcl 2 20%
• Immobility 20%